Recognition where it’s due: the Access to Medicines Index and the pharma industry

Brexit, Britain and belly laughs: reflections of an Australian political tragic*

Crouching dragons and hidden tigers: the emergence of China’s life sciences sector

My failure as a Rockstar: lessons from technological change in the music industry

Universal health coverage and health technology assessment in Sub-Saharan Africa

Doing it for Jane: eradicating tuberculosis

Access Accelerated: NCDs and the pharmaceutical industry’s coming of age

Black swans, disruption and dealing with the unexpected: lessons from the 17th century

Building the dream or living in la-la land? – PBS reform 10 years on

Can we handle a cure?: the politics and economics of hepatitis C treatment

The NHS – what lessons from a 70-year-old system of universal health coverage?

To price or not to price, that is the question

Don't forget the future: Alzheimer's disease and the economics of drug development

World Health Assembly: a change in the air?

Anti-vaxxers should read Roald Dahl

UK-Australia trade deal an opportunity for life sciences in both countries

Universal health coverage needs a new political campaign

A right balls-up: organisational decision making under pressure

Disruptive innovation in the health sector – are we ready for it?

Innovation policy is the new black